Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 2 EP applications Petra Pielken has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11723884

NOVEL INTERFERON-ALPHA-PRODUCING BONE MARROW DENDRITIC CELLS

IPC classification:
A61K 39/00, C12N 5/0784
Applicant:
Bavarian Nordic A/S
Agent:
Multiple attorneys, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP11701949

VACCINIA VIRUS MUTANTS CONTAINING THE MAJOR GENOMIC DELETIONS OF MVA

IPC classification:
A61K 39/00, C12N 7/00, C12N 7/02, C12N 15/86
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Bavarian Nordic GmbH
Status:
PATENT GRANTED

Please Sign in to use this feature